ZA77248B - Piperazine derivatives - Google Patents

Piperazine derivatives

Info

Publication number
ZA77248B
ZA77248B ZA770248A ZA77248A ZA77248B ZA 77248 B ZA77248 B ZA 77248B ZA 770248 A ZA770248 A ZA 770248A ZA 77248 A ZA77248 A ZA 77248A ZA 77248 B ZA77248 B ZA 77248B
Authority
ZA
South Africa
Prior art keywords
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
ZA770248A
Other languages
English (en)
Inventor
R Cyhrus
M Raschack
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of ZA77248B publication Critical patent/ZA77248B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA770248A 1976-02-07 1977-01-17 Piperazine derivatives ZA77248B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762604845 DE2604845A1 (de) 1976-02-07 1976-02-07 Neue piperazinderivate

Publications (1)

Publication Number Publication Date
ZA77248B true ZA77248B (en) 1977-11-30

Family

ID=5969327

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA770248A ZA77248B (en) 1976-02-07 1977-01-17 Piperazine derivatives

Country Status (25)

Country Link
US (1) US4079137A (fi)
JP (1) JPS52105186A (fi)
AT (1) AT355578B (fi)
AU (1) AU504526B2 (fi)
BE (1) BE850492A (fi)
CA (1) CA1094560A (fi)
CH (1) CH631448A5 (fi)
CS (1) CS201544B2 (fi)
DD (1) DD128133A5 (fi)
DE (1) DE2604845A1 (fi)
DK (1) DK138891C (fi)
ES (1) ES455691A1 (fi)
FI (1) FI63226C (fi)
FR (1) FR2340311A1 (fi)
GB (1) GB1550545A (fi)
HU (1) HU173483B (fi)
IE (1) IE44339B1 (fi)
IL (1) IL51316A (fi)
LU (1) LU76706A1 (fi)
NL (1) NL7700841A (fi)
NO (1) NO142625C (fi)
PL (1) PL105526B1 (fi)
PT (1) PT66154B (fi)
SE (1) SE7701187L (fi)
ZA (1) ZA77248B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US4483988A (en) * 1980-03-14 1984-11-20 Richardson Merrell Inc. Substituted derivatives of 4-t-alkoxycarbonyl-piperazin-2-ones
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
EP1835931A4 (en) * 2004-12-06 2008-12-17 Sciclone Pharmaceuticals Inc ALPHA THYMOSINE PEPTIDES AS CANCER VACCINE ADJUVANTIES
US20080300166A1 (en) * 2007-06-01 2008-12-04 Sciclone Pharmaceuticals, Inc. Treatment of Melanoma with Alpha Thymosin Peptides
US20100330093A1 (en) * 2007-12-12 2010-12-30 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with antibodies against cytotoxic t lymphocyte-associated antigen 4 (ctla4)
CA2708229A1 (en) * 2007-12-13 2009-06-18 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with a kinase inhibitor
CA2708168A1 (en) * 2007-12-14 2009-06-25 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa)
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
JP2012526149A (ja) * 2009-05-08 2012-10-25 サイクローン・ファーマシューティカルズ・インコーポレイテッド ワクチン増強剤としてのαチモシンペプチド
CA2962451C (en) 2014-10-21 2023-01-17 Sciclone Pharmaceuticals, Inc. Treatment of cancer with immune stimulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472856A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((thianaphthenyl)-lower-alkyl)-4-substituted-piperazines
DE2438725A1 (de) * 1974-08-12 1976-02-26 Knoll Ag Piperazinderivate
US4031216A (en) * 1974-08-12 1977-06-21 Knoll A.G. Chemische Fabriken 3-(3,4-Dialkoxy-benzyl)-3-methyl-piperazines

Also Published As

Publication number Publication date
CS201544B2 (en) 1980-11-28
NO142625B (no) 1980-06-09
AU2195277A (en) 1978-08-10
PT66154A (fr) 1977-03-01
IL51316A (en) 1980-12-31
DK49077A (da) 1977-08-08
AT355578B (de) 1980-03-10
FR2340311A1 (fr) 1977-09-02
ES455691A1 (es) 1978-01-01
DK138891B (da) 1978-11-13
SE7701187L (sv) 1977-08-08
NO142625C (no) 1980-09-17
BE850492A (fr) 1977-07-18
HU173483B (hu) 1979-05-28
PL105526B1 (pl) 1979-10-31
PT66154B (fr) 1978-07-07
AU504526B2 (en) 1979-10-18
JPS52105186A (en) 1977-09-03
FI770398A (fi) 1977-08-08
DK138891C (da) 1979-04-23
FI63226B (fi) 1983-01-31
FR2340311B1 (fi) 1980-02-08
GB1550545A (en) 1979-08-15
NL7700841A (nl) 1977-08-09
US4079137A (en) 1978-03-14
DD128133A5 (de) 1977-11-02
FI63226C (fi) 1983-05-10
LU76706A1 (fi) 1977-06-28
IE44339L (en) 1977-08-07
DE2604845A1 (de) 1977-08-18
CH631448A5 (de) 1982-08-13
ATA68177A (de) 1979-08-15
CA1094560A (en) 1981-01-27
IE44339B1 (en) 1981-10-21
NO770374L (no) 1977-08-09
IL51316A0 (en) 1977-03-31

Similar Documents

Publication Publication Date Title
NZ185971A (en) Morpholine derivatives
JPS5612375A (en) Morpholine derivative
GB1545094A (en) Piperazine derivatives
GB1541547A (en) 4-phenoxymethylpiperidine derivatives
IL52002A0 (en) M-phenoxybenzamide derivatives
GB1521020A (en) 4-hydrox-aporphine derivatives
GB1550545A (en) Piperazine derivatives
GB1543124A (en) 2-iminothiazolidine derivatives
GB1554517A (en) Nogarol derivatives
NZ183715A (en) Phenylpiperazine derivatives
AU513087B2 (en) l-Substituted-4-fusedbenzyl piperazine derivatives
JPS52105138A (en) Novellphenyll22aminoethanol derivatives
GB1553759A (en) Tetrahyddropyridine derivatives
GB1523198A (en) Thiazolo-rifamycin derivatives
GB1549755A (en) N-4-halobutyryl derivatives
IL52270A0 (en) Hydrazinopyridazine derivatives
GB1524481A (en) Tetrahydo - imidazopyridine derivatives
GB1550544A (en) Alkylenedioxybenzyl piperazine derivatives
GB1545021A (en) 5-norbicyclomycin derivatives
JPS52100431A (en) Anilinoacetate derivatives
GB1550656A (en) Morpholine derivatives
ZA772148B (en) Substituted piperazine derivatives
GB1535080A (en) Naphthacenequinone derivatives
GB1544289A (en) Thiazolinotriazine derivatives
JPS5283495A (en) Thienothiazine derivatives